AT-02

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameAT-02
Drug Alias NameAT-02
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPhagocytes stimulantsImmunoglobulin G inhibitors
TargetsImmunoglobulin G
Therapy Area/IndicationsAmyloidosisImmunoglobulin Light-chain Amyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAttralus Inc
China Registration ClassN/A

Develop Information

Active CompaniesAttralus Inc
Inactive CompaniesN/A
Active IndicationsAmyloidosisImmunoglobulin Light-chain Amyloidosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A